Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ANIP
#2070
ANI Pharmaceuticals, Inc.
77.840
0
USD
-0.60%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.60%
Changement Mensuel
+9.99%
Evolution sur 6 mois
-17.74%
Changement Annuel
-17.74%
Clôture Précédente
78.310
0
Open
77.950
0
Bid
Ask
Low
77.789
3
High
78.010
0
Volume
15
Marchés
Actions des Marchés US
Soins de Santé
ANIP
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
—
Valuation ratios
Enterprise value
523.97 M
983.5 M
940.37 M
1.27 B
1.37 B
1.79 B
6.99 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
-77.89
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
1.9
7.81
Price to cash flow ratio
22.76
174.72
-20.86
8.75
16.68
9.05
45.65
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
5.7
Enterprise value to EBITDA ratio
23.96
68.32
21.63
19.62
7.92
12.28
63.6
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.06
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.16
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.73
34
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
246.07
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
49.84
EBITDA margin %
21.41
15.49
30.02
35.55
71.25
30
140.79
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
34.81
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
8.17
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
10.49
Inventory turnover
—
1.41
1.48
1.68
2.02
2.44
2.42
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.65
0.65
Solvency ratios
Debt to assets ratio
0.37
0.37
0.38
0.32
0.25
0.21
0.89
Debt to equity ratio
0.88
0.86
0.92
0.67
0.78
0.56
2.58
Long term debt to total assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.87
Long term debt to total equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
2.55
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9
EBIT per share
-1.34
-3.16
-2.17
2.58
0.03
5.23
5.35
EBITDA per share
3.73
2.66
5.84
9.51
22.66
12.48
15.26
Total debt per share
14.44
22.86
17.7
15.97
16.32
14.27
58.7
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
44.1
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
125.02
Tangible book value per share
0.3
0.94
2.08
10.75
-10.26
-0.06
-18.84
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
77.36
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
91.84
Nouvelles
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
ANI Pharmaceuticals lance des comprimés génériques de mononitrate d’isosorbide
ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa